Table 5 The susceptibility profile of carbapenem-resistant and ESBL-producer E. coli, Pseudomonas spp., and K. pneumoniae isolates against different antimicrobial classes
Sensitivity rate (n, %) | 4th GC | Ciprofloxacin | AGs | BL/BLI | Polymyxins | Carbapenems |
|---|---|---|---|---|---|---|
Carbapenem-resistant | ||||||
 E. coli | 16 (53.3%) | 8 (26.7%) | 9 (30%) | 11 (36.7%) | 18 (69.2%) | – |
 Pseudomonas spp. | 35 (60.3%) | 54 (93.1%) | 51 (78.9%) | 47 (81%) | 6 (66.6%) | – |
 K. pneumoniae | 2 (40%) | 1 (20%) | 2 (25%) | 2 (40%) | 5 (62.5%) | – |
ESBL | ||||||
 E. coli | 20 (28.6%) | 17 (24.3%) | 38 (54.3%) | 21 (30%) | 59 (84.3%) | 51 (72.9%) |
 Pseudomonas spp. | 52 (69.3%) | 71 (94.7%) | 70 (93.3%) | 53 (70.7%) | 41 (54.7%) | 20 (26.7%) |
 K. pneumoniae | 7 (35%) | 6 (30%) | 16 (80%) | 1 (5%) | 6 (75%) | 17 (85%) |
MDR | ||||||
 E. coli | 42 (46.2%) | 19 (20.9%) | 40 (44%) | 27 (29.7%) | 71 (78%) | 62 (68.1%) |
 Pseudomonas spp. | 51 (68.9%) | 70 (94.6%) | 67 (90.5%) | 49 (66.2%) | 37 (50%) | 18 (24.3%) |
 K. pneumoniae | 11 (45.8%) | 6 (25%) | 15 (62.5%) | 3 (12.5%) | 19 (79.2%) | 19 (79.2%) |